BREAKING: FDA approves Emergency Use Authorization for Johnson & Johnson COVID-19 vaccine | News


BREAKING: FDA approves Emergency Use Authorization for Johnson & Johnson COVID-19 vaccine | News

The FDA has approved Emergency Use Authorization for the Johnson & Johnson COVID-19 vaccine. 

The shot is a single dose vaccine. 

“After a thorough analysis of the data, the FDA’s scientists and physicians have determined that the vaccine meets the FDA’s expectations for safety and effectiveness appropriate for the authorization of a vaccine for emergency use,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “With today’s authorization, we are adding another vaccine in our medical toolbox to fight this virus. At the same time, the American people can be assured of the FDA’s unwavering commitment to public health through our comprehensive and rigorous evaluation of the data submitted for vaccines to prevent COVID-19.”

One dose is roughly 85% effective against the most severe COVID-19 illness.


Source link